Citations 2
92 | EO2463 (EO) PEPTIDE IMMUNOTHERAPY IN COMBINATION WITH LENALIDOMIDE (L) AND RITUXIMAB (R) IN PATIENTS (PTS) WITH FOLLICULAR (FL) AND MARGINAL ZONE LYMPHOMA (MZL)
Wallace, D. S., Smith, Stephen D. , García, Carlos Grande, Marolleau, Jean Pierre, García, C. Bousoño , Rinaudo, Paolo , Chêne, Laurent , Fagerberg, Jan , Friedberg, Jonathan W. , Armand, P., Ansell, Stephen M. , Villasboas, José C. , Bosch, Francesc Xavier , Pinto, Antonio , Merryman, Reid W. , Arcaini, Luca , Gutiérrez, Norma C. , Marolleau, Jean‐Pierre, Till, Brian G. , García, C., Filippi, Rosaria De , Rinaudo, P., Fagerberg, J., Zinzani, Pier Luigi
Hematological Oncology | June 16, 2025 | Volume: 43 | Issue: S3 | Pages: No page available
Phase 1 trial of EO2463 peptide‐based immunotherapy as monotherapy and in combination with lenalidomide and rituximab in indolent non‐Hodgkin lymphoma; EONHL1‐20/SIDNEY
Pinto, A. A., Bisneto, J. C. Villasboas, Sanz, R. García, García, Carlos Grande, Smith, Stephen D. , Wallace, D. S., Merryman, R., Marolleau, Jean Pierre, Chêne, Laurent , Fagerberg, Jan, Friedberg, Jonathan W. , Ansel, Sonam , Armand, Philippe , Pinto, A., Bosch, Francesc , Bisneto, J. C. Villasboas, Sanz, R. García, Arcaini, Luca , Marolleau, Jean‐Pierre, Filippi, Rosaria De , Bonny, Christophe , Ansel, S., Zinzani, Pier Luigi
Hematological Oncology | June 9, 2023 | Volume: 41 | Issue: S2 | Pages: 581-582